BONUSCAP-ZERTIFIKAT - PFIZER INC Stock

Certificat

DE000HC7MY62

Market Closed - BOERSE MUENCHEN 15:46:24 2024-05-24 EDT
28.34 EUR -0.04% Intraday chart for BONUSCAP-ZERTIFIKAT - PFIZER INC
Current month+13.95%
1 month+10.96%
Date Price Change
24-05-24 28.34 -0.04%
24-05-23 28.35 -2.04%
24-05-22 28.94 +2.73%
24-05-21 28.17 +0.28%
24-05-20 28.09 -0.28%

Real-time BOERSE MUENCHEN

Last update May 24, 2024 at 03:46 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC7MY6
ISINDE000HC7MY62
Date issued 2023-06-23
Strike 42 $
Maturity 2024-12-20 (209 Days)
Parity 1 : 1
Emission price 37.26
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 37.8
Lowest since issue 24.5

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.88 USD
Average target price
31.94 USD
Spread / Average Target
+10.59%
Consensus